(NASDAQ: PLSE) Pulse Biosciences's forecast annual revenue growth rate of 145.18% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.27%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.33%.
Pulse Biosciences's revenue in 2026 is $1,185,000.On average, 6 Wall Street analysts forecast PLSE's revenue for 2026 to be $143,929,021, with the lowest PLSE revenue forecast at $111,833,848, and the highest PLSE revenue forecast at $164,755,222. On average, 6 Wall Street analysts forecast PLSE's revenue for 2027 to be $425,581,996, with the lowest PLSE revenue forecast at $111,833,848, and the highest PLSE revenue forecast at $655,312,113.
In 2028, PLSE is forecast to generate $1,374,957,218 in revenue, with the lowest revenue forecast at $111,833,848 and the highest revenue forecast at $2,695,994,545.